Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Boehringer Ingelheim (consumer healthcare business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

10 pharmaceutical brand names. The Consumer Health Care business includes the following brand names like Antistax®, Bisolvon®, Buscopan®, Dulcolax®, Eve®, Mucoangin®, Mucosolvan®, Pharmaton®, Thomapyrin® and Zantac®. These medicines are effective for cough and cold, sore throat, general pain, gastro-intestinal disorders and vitamins and minerals for physical and mental well-being.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Binger Strasse 173
  • 55216 Ingelheim / Rhein
  • Germany

Boehringer Ingelheim (consumer healthcare business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Boehringer Ingelheim (consumer healthcare business)‘s full profile, request access.

Request full access to PitchBook

Boehringer Ingelheim (consumer healthcare business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Boehringer Ingelheim (consumer healthcare business)‘s full profile, request access.

Request full access to PitchBook